Abstract:Background: Circular RNAs (circRNAs), a novel type of ncRNAs, are covalently linked to make up circular configuration via a loop structure. Accumulating evidence indicate that circRNAs are potential biomarkers and key regulators in the development and progression of tumors. However, the precise role of circRNAs in renal cell carcinoma (RCC) remains unknown.Methods: Though circRNA high-throughput sequencing from RCC cell lines, we determined circRNA TLK1 (circTLK1 ) as a novel candidate circRNA derived from TLK1 gene. Quantitative real-time PCR (qRT-PCR) was performed to detect the expression levels of mRNAs, circRNAs and miRNAs in RCC tissues and cells. Loss-of function experiments were executed to detect the biological roles of circTLK1 on the phenotypes of RCC cells in vitro and in vivo. RNA-FISH, RNA-pull down, dual-luciferase reporter, western blot and immunohistochemistry assay were used to investigate the molecular mechanisms underlying the functions of circTLK1.Findings: CircTLK1 is overexpressed in RCC and positively corelated with distant metastasis and unfavorable prognosis. Silence of circTLK1 significantly inhibits the proliferation, migration and invasion of RCC cells in vitro and in vivo. Mechanistically, circTLK1 is mainly distributed in the cytoplasm and positively regulates CBX4 expression by sponging miR-136-5p. In addition, forced expression of CBX4 reverses the phenotypes inhibition of RCC cells induced by circTLK1 suppression. Moreover, CBX4 expression is positively corelated with VEGF expression in renal cancer tissues. Knockdown of CBX4 significantly inhibited VEGF expression in RCC cells.Interpretation: Collectively, our findings demonstrate that circTLK1 plays a critical role in RCC progression by sponging miR-136-5p to increase CBX4 expression. CircTLK1 may act as a diagnostic biomarker and therapeutic target for RCC.Funding Statement: This study was supported by grants from Guangdong Key Laboratories (2017B030314074) and the Shenzhen Project of Science and Technology (JCYJ20170413100245260).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: This study was approved by the ethical committee of Perking University Shenzhen Hospital. All patients agreed that their samples could be applied to the experimental studies and paper presentations.In vivo assay was approved by the animal management committee of Perking University Shenzhen Hospital, and all experimental procedures and animal care were in line with the institutional ethics guidelines for animal experiments.

RUVBL1 accelerates tongue squamous cell carcinoma by mediating CRaf/MEK/ERK pathway

Knockdown of LRP5 Promotes Proliferation and Invasion of Tongue Squamous Cell Carcinoma Through Compensatory Activation of Akt Signaling

Regulation of the β‐catenin/LEF‐1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion

Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma

RUVBL1 in Clear-Cell Renal Cell Carcinoma: Unraveling Prognostic Significance and Correlation with HIF1A

RUVBL1-modulated Chromatin Remodeling Alters the Transcriptional Activity of Oncogenic CTNNB1 in Uveal Melanoma

Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling

Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.

Downregulation Of The Rho Gtpase Signaling Pathway Is Involved In The Microrna-138-Mediated Inhibition Of Cell Migration And Invasion In Tongue Squamous Cell Carcinoma

miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

LncRNA THOR promotes tongue squamous cell carcinomas by stabilizing IGF2BP1 downstream targets.

RRM2 Is a Putative Biomarker and Promotes Bladder Cancer Progression via PI3K/AKT/mTOR Pathway

<scp>MRTF‐A</scp>/<scp>SRF</scp> signaling suppresses invasion of oral squamous cell carcinoma

TGFβ1‐Smad3‐Jagged1‐Notch1–Slug Signaling Pathway Takes Part in Tumorigenesis and Progress of Tongue Squamous Cell Carcinoma

LncRNA CCAT1 knockdown suppresses tongue squamous cell carcinoma progression by inhibiting the ubiquitination of PHLPP2

Isoprenylcysteine carboxyl methyltransferase promotes the progression of tongue squamous cell carcinoma via the K-Ras and RhoA signaling pathways

RUVBL1 ubiquitination by DTL promotes RUVBL1/2-β-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer

Combined CRISPRi and Proteomics Screening Reveal a Cohesin-Ctcf-bound Allele Contributing to Increased Expression of RUVBL1 and Prostate Cancer Progression

Dysregulation of AKT1, a miR-138 target gene, is involved in the migration and invasion of tongue squamous cell carcinoma.

CircTLK1 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Through Sponging Mir-136-5p and Regulating CBX4 Expression

RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis